Speakers

Moderator

dr. Sri Suryo Adiyanti, M.Kes., Sp.PK(K)

The Roles of Diabetes, Atherosclerosis, and Atherothrombosis in ASCVD Pathogenesis

dr. Sidhi Laksono, Sp.JP, Subsp.KI(K), FIHA, MARS, MH, CPHM, FisQUA

Diabetes and Lipid Profile Examinations for ASCVD Risk Assessment

dr. Tjan Sian Hwa, M.Sc, Sp.PK

Coagulation Evaluations for Ensuring Effective CVD Treatments

Dr. dr. Usi Sukorini, M.Kes., Sp.PK(K)

Lecture Abstract

In the past 30 years, global cardiovascular diseases (CVDs) have doubled to 523 million cases, witha mortality rate of 18.6 million per year. CVDs, especially ischaemic heart disease, are the leading nglobal cause of death and economic burden. While high-income countries see a decline, low- and middle-income countries, like most countries in the Asia Pacific region, witness rising mortality, especially among younger populations.

Prevention should focus on managing modifiable risk factors, such as hyperlipidaemia, hypertension, smoking, and diabetes. Clinical chemistry and coagulation tests are crucial for understanding and managing atherosclerotic cardiovascular disease (ASCVD) risk.

We hoped you have enjoyed the webinar and gained new insights!

May we request your time for a short survey?